No Data
No Data
No Data
No Data
No Data
Madrigal Announces US Launch of NASH/MASH Drug Rezdiffra
Seeking AlphaApr 9 10:03 ET
Akero Therapeutics(AKRO.US) Officer Sells US$121.91K in Common Stock
$Akero Therapeutics(AKRO.US)$ Officer Young Jonathan sold 5,000 shares of Common Stock on Apr 1, 2024 at an average price of $24.3826 for a total value of $121.91K.Source: Announcement What is stateme
moomoo NewsApr 3 19:37 ET
Ademi LLP Investigates Claims of Securities Fraud Against Akero Therapeutics, Inc.
MILWAUKEE, April 2, 2024 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Akero (Nasdaq: AKRO). The investigation results from inaccurate statements Akero may have
PR NewswireApr 2 18:05 ET
Form 144 | Akero Therapeutics(AKRO.US) Officer Proposes to Sell 379.2K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 1, $Akero Therapeutics(AKRO.US)$ Officer Jonathan Young intends to sell 15,000 shares of its common stock on Apr 1, with a total market value of approximately $379.2K. S
moomoo NewsApr 1 16:24 ET
Billionaire Steve Cohen and Insiders Are Buying These 10 Stocks
Yahoo FinanceMar 20 13:32 ET
Inventiva Phase 2 Study for MASH Drug Meets Primary Endpoint
Seeking AlphaMar 18 17:45 ET
No Data
No Data